Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06729788

Resin Infiltrate as Pit and Fissure Sealant in Permanent Molars

Evaluation of Resin Infiltrate as Pit and Fissure Sealant in Permanent Molars (In Vivo& In Vitro)

Status
Not Yet Recruiting
Phase
Phase 4
Study type
Interventional
Enrollment
86 (estimated)
Sponsor
Tanta University · Academic / Other
Sex
All
Age
6 Years – 8 Years
Healthy volunteers
Accepted

Summary

The aim of this study is to evaluate and compare the clinical effectiveness of ICON resin Infiltration versus conventional sealant and the microleakage and penetration depth of the two sealant materials.

Detailed description

Using the resin infiltration technique as a different approach for sealing pits and fissures creates a diffusion barrier as resin infiltrate tends to inhibit enamel pores that serve as diffusion channels for acids and dissolved minerals within the lesion body. A low-viscosity resin that can penetrate into caries lesions, which is referred to as resin infiltration technique. The mechanisms associated with this method depend on the infiltration of subsurface lesions with low-viscosity light-curing resins after eroding the highly mineralized surface layer and increasing penetration depth. This method is believed to overcome the limitations of sealant applications and is considered to be a better alternative for the treatment of initial caries lesions.

Conditions

Interventions

TypeNameDescription
DRUGICON resin infiltration Material group in vivoThe fissure of selected teeth will be sealed with ICON resin infiltration Material (DMG Dental UK).
DRUGResin-based fissure sealant group in vivoThe fissure of selected teeth will be sealed with resin-based fissure sealant (Heliosael)
DRUGICON resin infiltration in vitroThe fissure of selected teeth will be sealed with ICON resin infiltration Material (DMG Dental UK) in vitro
DRUGResin-based fissure sealant in vitroThe fissure of selected teeth will be sealed with resin-based fissure sealant (Heliosael) in vitro

Timeline

Start date
2025-01-04
Primary completion
2025-11-15
Completion
2025-12-24
First posted
2024-12-11
Last updated
2024-12-11

Locations

1 site across 1 country: Egypt

Regulatory

Source: ClinicalTrials.gov record NCT06729788. Inclusion in this directory is not an endorsement.